DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Report
June 17, 2024
Schizophrenia – Current Treatment – Current Treatment: Physician Insights – Schizophrenia (US)
In the United States, atypical antipsychotics available in oral and injectable (e.g., long-acting injectable [LAI]) formulations are the mainstay of schizophrenia treatment. However, the dearth of…
Report
June 14, 2024
Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Unmet Need – Unmet Need – Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Leukemia (US/EU)
Chronic lymphocytic leukemia (CLL) / small lymphocytic lymphoma (SLL) is a type of B-cell non-Hodgkin’s lymphoma and represents the most common form of leukemia in adults. The R/R CLL treatment…
Report
June 12, 2024
Post-Traumatic Stress Disorder – Executive Insights – Executive Insights – Post-Traumatic Stress Disorder (US)
Post-traumatic stress disorder (PTSD) is a chronic psychiatric condition that may emerge after a person experiences a traumatic event or series of events. Multiple guidelines recommend first…
